Ameritas Investment Partners, Inc. Savara Inc Transaction History
Ameritas Investment Partners, Inc.
- $2.86 Billion
- Q1 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Savara Inc stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 9,054 shares of SVRA stock, worth $38,932. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,054
Previous 9,054
-0.0%
Holding current value
$38,932
Previous $42,000
7.14%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SVRA
# of Institutions
122Shares Held
121MCall Options Held
123KPut Options Held
14.7K-
Nea Management Company, LLC Timonium, MD24.5MShares$105 Million8.55% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$62.6 Million10.96% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10MShares$43 Million5.24% of portfolio
-
Jennison Associates LLC8.84MShares$38 Million0.03% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.29MShares$35.6 Million0.08% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $490M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.